Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278740
Max Phase: Preclinical
Molecular Formula: C47H40N4O3
Molecular Weight: 708.86
Associated Items:
ID: ALA5278740
Max Phase: Preclinical
Molecular Formula: C47H40N4O3
Molecular Weight: 708.86
Associated Items:
Canonical SMILES: COc1ccc(-c2nc(-c3ccccc3)c(-c3ccccc3)n2C(NN(c2ccccc2)c2cccc3ccccc23)c2ccccc2)c(OC)c1OC
Standard InChI: InChI=1S/C47H40N4O3/c1-52-41-32-31-39(44(53-2)45(41)54-3)47-48-42(34-20-8-4-9-21-34)43(35-22-10-5-11-23-35)50(47)46(36-24-12-6-13-25-36)49-51(37-27-14-7-15-28-37)40-30-18-26-33-19-16-17-29-38(33)40/h4-32,46,49H,1-3H3
Standard InChI Key: SCEPKILMSOYURH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 708.86 | Molecular Weight (Monoisotopic): 708.3100 | AlogP: 10.95 | #Rotatable Bonds: 12 |
Polar Surface Area: 60.78 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 4.44 | CX LogP: 11.02 | CX LogD: 11.02 |
Aromatic Rings: 8 | Heavy Atoms: 54 | QED Weighted: 0.13 | Np Likeness Score: -0.39 |
1. Shaveta, Mishra S, Singh P.. (2016) Hybrid molecules: The privileged scaffolds for various pharmaceuticals., 124 [PMID:27598238] [10.1016/j.ejmech.2016.08.039] |
Source(1):